A selfreplicating RNA Precision Immunotherapeutic for Overcoming Resistance to Endocrine Therapy in Estrogen Receptor Positive Breast Cancer (ER plus BC)

被引：0
|
作者：
Goldberg, Zelanna
Maine, Christian
Dailey, Gabrielle
Domingo, Christine
Picarda, Gaelle
Little, Hunter
Chou, Annie
Sparks, Jessica
Spasova, Darina
Miyake-Stoner, Shiegeki
Hartman, Zachary C.
Rabiola, Christopher
Crosby, Erika
Lyerly, Herbert
Wang, Nathaniel
Aliahmad, Parinaz
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO3-26-06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO3-26-06
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Epigenetic mechanisms of cancer progression and therapy resistance in estrogen-receptor (ER plus ) breast cancer
    Toska, Eneda
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (03):
  • [22] Evolution of genomic alterations on endocrine therapy and mTOR inhibition in estrogen receptor (ER)-positive breast cancer
    Massarweh, S.
    Romond, E.
    Stewart, R.
    Sun, J.
    Chmielecki, J.
    Mehdi, M.
    Black, E. P.
    CANCER RESEARCH, 2016, 76
  • [23] PELP-1 regulates adverse endocrine responses to endocrine therapy in Estrogen Receptor (ER) positive breast cancer
    Rees, M.
    Smith, C.
    Hiscox, S.
    Barrett-Lee, P.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S121 - S122
  • [24] Vandetanib to Overcome Endocrine Resistance in Estrogen Receptor Positive Breast Cancer
    Kakati, Rasha
    Whitman, Austin A.
    Kim, Hyunsoo
    Molina, Sarahi G.
    Beltran, Adriana S.
    Spanheimer, Philip M.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 235 (05) : S6 - S7
  • [25] Endocrine resistance and epigenetic reprogramming in estrogen receptor positive breast cancer
    Dimitrakopoulos, Foteinos-Ioannis
    Kottorou, Anastasia
    Tzezou, Aspasia
    CANCER LETTERS, 2021, 517 : 55 - 65
  • [26] Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancer
    Jones, Veronica
    Yin, Hongwei Holly
    Yuan, Yate-Ching
    Wang, Yongzhe
    Li, Sierra Min
    Aljaber, Dana
    Sanchez, Angelica
    Quinones, Christine
    Schmolze, Dan
    Yuan, Yuan
    Mortimer, Joanne
    Yee, Lisa
    Kruper, Laura
    Jovanovic-Talisman, Tijana
    Tomsic, Jerneja
    Sanchez, Nancy
    Chavez, Tanya
    O'Regan, Ruth M.
    Khan, Qamar J.
    Davis, Melissa
    Kalinsky, Kevin
    Meisel, Jane
    Kittles, Rick
    Rodriguez-Rodriguez, Lorna
    Seewaldt, Victoria
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [27] Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
    Anishka D’Souza
    Darcy Spicer
    Janice Lu
    Journal of Hematology & Oncology, 11
  • [28] Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
    D'Souza, Anishka
    Spicer, Darcy
    Lu, Janice
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [29] Towards Precision Radiation Oncology: Endocrine Therapy Resistance as a Biomarker for Radiation Resistance in ER-Positive Breast Cancer
    Udden, S. M. Nashir
    Rahimi, Asal
    Kim, Dong W. Nathan
    Alluri, Prasanna
    CANCER RESEARCH, 2023, 83 (05)
  • [30] Tamoxifen Resistance in Estrogen Receptor Positive (ER plus ) Breast Cancer Is Driven by Estrogen Receptor Negative (ER-) Cancer Stem-Like Cells.
    O'Brien, C. S.
    Howell, S. J.
    Gee, J.
    Lykkesfeldt, A. E.
    Nicholson, R., I
    Clarke, R. B.
    CANCER RESEARCH, 2009, 69 (24) : 807S - 807S
12345